Stock Market
Tempest Therapeutics GAAP Earnings Miss Expectations
By Bullbit Editorial ยท March 30, 2026
- WhatTempest Therapeutics reported GAAP EPS of -$6.33, missing expectations.
- WhyThe company's financial performance fell short of market forecasts.
- SignalThis earnings miss may indicate underlying business challenges.
- TargetInvestors will be closely watching Tempest Therapeutics' future financial guidance.
- RiskThe company's stock price may be vulnerable to further declines.
More breaking news โ